首页> 外文OA文献 >PIH53 Alpha Blockers, 5-Alpha Reductase Inhibitors, PDE-5 Inhibitors and Antimuscarinic Medication Use in US Patients Diagnosed with Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms with and Without Erectile Dysfunction

【2h】

PIH53 Alpha Blockers, 5-Alpha Reductase Inhibitors, PDE-5 Inhibitors and Antimuscarinic Medication Use in US Patients Diagnosed with Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms with and Without Erectile Dysfunction

机译：PIH53α受体阻滞剂，5-α还原酶抑制剂，PDE-5抑制剂和抗毒蕈碱药物在美国诊断为良性前列腺增生和有或没有勃起功能障碍的下尿路症状患者中的使用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Burge R.; Le T.K.; Viktrup L.; Watts S.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both? [J] . Carson CC BJU international . 2006,第Suppla2期

机译：良性前列腺增生患者中磷酸二酯酶5抑制剂和α受体阻滞剂的组合：下尿路症状，勃起功能障碍或两者的治疗？
2. Progression of lower urinary tract symptoms after discontinuation of 1 medication from 2-year combined alpha-blocker and 5-alpha-reductase inhibitor therapy for benign prostatic hyperplasia in men - A randomized multicenter study [J] . LinV.C.-H., LiaoC.-H., KuoH.-C. Urology . 2014,第2期

机译：男性良性前列腺增生2年联合使用α-受体阻滞剂和5-α-还原酶抑制剂联合治疗停止1种药物治疗后下尿路症状的进展-一项随机的多中心研究
3. Effects of Withdrawing alpha 1-Blocker from Combination Therapy with alpha 1-Blocker and 5 alpha-Reductase Inhibitor in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Prospective and Comparative Trial Using Urodynamics [J] . Matsukawa Yoshihisa, Takai Shun, Funahashi Yasuhito, The Journal of Urology . 2017,第4期

机译：α1-嵌体和5α-还原酶抑制剂中α1-r-r-r-r-r-r-r-r-r-r-r-r-r-r-r-r-r-r-r-r-r-r-r-r-stave and 5α-还原酶抑制剂暗示良性前列腺增生：使用鞋髓的前瞻性和比较试验
4. Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis [O] . Chengquan Ma, Jianzhong Zhang, Zhonglin Cai, 2020

机译：用坦索罗辛定义磷酸二酯酶5型抑制剂治疗伴或不伴勃起功能障碍的良性前列腺增生引起的下尿路症状的功效和安全性：网络荟萃分析
5. Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis [O] . Chengquan Ma, Jianzhong Zhang, Zhonglin Cai, 2020

机译：定义磷酸二磷酸酯蛋白酶型5抑制剂的疗效和安全性，用于治疗患有或不带勃起功能障碍的良性前列腺增生的下泌尿道症状：网络元分析

PIH53 Alpha Blockers, 5-Alpha Reductase Inhibitors, PDE-5 Inhibitors and Antimuscarinic Medication Use in US Patients Diagnosed with Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms with and Without Erectile Dysfunction

著录项

引文网络

相似文献

相关主题

期刊订阅